RESUMO
To evaluate the efficacy and safety of a newly developed axillary brachial plexus anesthesia by a modified technique in basilac vien superflcialization arterio-venous fistula as a sole anesthetic agent in patients with end stage renal disease. Forty patients were studied aged [30-60yrs]. All patients with end-stage renal disease and underwent basilac vien mobilization A-Vfistula. Patients were classified into two equal groups, group A in which we tried our new modfled [open] axilary brachial plexus block and group B where traditional axillary brachial plexus block was used. Sensory and motor block were assessed at 0, 5,10, 20, 30 min and then 1 and 2 hours. Any analgesics, sedatives, and anesthetics given to the patient was recorded. In group A there was a significant increase in the number of patients with adequate sensory/motor block for surgical anesthesia [90%] while it was [60%] in group B also time of onset of sensory block was significant by shorter in group A. Total failure was [15%] in group B and [25%] had incomplete block requiring either local infiltration or general anesthesia vs no failure[0%] in group A. The modified brachial plexus block could be introduced as safe and effective new technique in blocking axillary brachial plexus. However this maneuver could be used as sole anesthetic agent selectively in patients underwent basilac vein mobilization A-V fistula